Is this you? Create Your Porfile
Avatar

Charles Hart

Merck & Co.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Charles Hart is active.

Explore More

Publication

Featured researches published by Charles Hart.

Archive | 2011

ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER

Charles Hart; John G. Curd; Stewart Kroll; Jessica Sun

Archive | 2011

Treatment of blood cancer

John G. Curd; Damian Handisides; Charles Hart; Stewart Kroll

Archive | 2016

Treatment of pancreatic cancer with a combination of a hypoxia-acti vated prodrug and a taxane

Charles Hart; Jessica D. Sun; Brian A. Elenbaas; Antonio Gualberto

Archive | 2012

Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer

Charles Hart; Fanying Meng; Jessica Sun

Archive | 2012

Hypoxia activated prodrugs and mtor inhibitors for treating cancer

Charles Hart; Jessica Sun; Fanying Meng

Archive | 2014

Predictive and response biomarker for th-302 anti-cancer therapy

Charles Hart; Harold E. Selick; Jessica Sun

Archive | 2015

DNA repair processes involved with the hypoxia-activated prodrug evofosfamide (TH-302): comparison to cisplatin and temozolomide

Fanying Meng; Deepthi Bhupathi; Charles Hart

Archive | 2014

Traitement d'un cancer du pancréas au moyen d'une combinaison d'un promédicament activé par l'hypoxie et d'un taxane

Charles Hart; Jessica Sun; Brian A. Elenbaas; Antonio Gualberto

Archive | 2012

acquisition of epithelial to mesenchymal transition-like features Hypoxia promotes dissemination of multiple myeloma through

Charles P. Lin; Andrew L. Kung; Ruben D. Carrasco; Karin Vanderkerken; Irene M. Ghobrial Thompson; Patricia Maiso; Jessica Sun; Charles Hart; Aldo M. Roccaro; Kareem Azab; Jinsong Hu; Phong Quang; Feda Azab; Costas Pitsillides; Rana Awwad

Archive | 2012

Enhancement of Hypoxia-Activated Prodrug TH-302 Activity by Chk1 Inhibition

Fanying Meng; Deepthi Bhupathi; Jessica Sun; Qian Liu; Mark D. Matteucci; Chris Torrance; Charles Hart

Explore More

Collaboration

Dive into the Charles Hart's collaboration.

Top Co-Authors
Avatar

Jessica Sun

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors
Avatar

Stewart Kroll

Corixa Corporation

View shared research outputs
Top Co-Authors
Avatar

Antonio Gualberto

Merck

View shared research outputs
Top Co-Authors
Avatar

Brian A. Elenbaas

Merck

View shared research outputs
Top Co-Authors
Avatar

Damian Handisides

Imperial College London

View shared research outputs
Top Co-Authors
Avatar

Aldo M. Roccaro

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Andrew L. Kung

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors
Avatar

Charles P. Lin

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Costas Pitsillides

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Feda Azab

Washington University in St. Louis

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge